Escient is a clinical-stage pharmaceutical company focused on developing novel therapeutics to address a broad range of neurosensory-inflammatory diseases. Our pipeline includes two first-in-class small molecule antagonists targeting MRGPRX2 for the treatment of various mast cell-mediated disorders and MRGPRX4 for cholestatic pruritus. Based in San Diego, California, Escient is led by an experienced team with specific expertise in GPCR drug discovery and development and funded by top-tier life science investors.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 10578 Science Center Drive,
- Phone
- 858.617.8220
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- escientpharma.com
- HQ
- San Diego, CA
Escient Pharmaceuticals Questions
Escient Pharmaceuticals's helpline number is 858.617.8220
Escient Pharmaceuticals's website is escientpharma.com
Escient Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/escientpharmaceuticals
Escient Pharmaceuticals has
21 employees.
View email and phone details for 21
employees at Escient Pharmaceuticals.
Escient Pharmaceuticals's industry is
Biotechnology Research
Escient Pharmaceuticals's top competitors are
Syndax Pharmaceuticals,
Longboard Pharmaceuticals,
Lexicon Pharmaceuticals, Inc.,
Biosion,
Evofem Biosciences,
Inhibrx Biosciences, Inc.,
Kura Oncology, Inc.,
Aclaris Therapeutics, Inc.,
Halozyme, Inc.,
Incyte.
Escient Pharmaceuticals's support email address is info@escientpharma.com
Escient Pharmaceuticals's categories are Biotechnology Research
Escient Pharmaceuticals's founding year is 2018
